Outlook Therapeutics Inc. (OTLK)
NASDAQ: OTLK
· Real-Time Price · USD
2.35
-0.08 (-3.29%)
At close: Aug 15, 2025, 3:59 PM
2.39
1.92%
After-hours: Aug 15, 2025, 07:49 PM EDT
Outlook Therapeutics Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 170.12K | 170.12K | 170.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 171.64K | 170.73K | 170.12K | 96.28K | 67.61K | 39.41K | 11.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 176.28K |
Gross Profit | -1.51K | -606 | n/a | -96.28K | -67.61K | -39.41K | -11.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -76.44M | -82.99M | -71.7M | -61.28M | -59.86M | -47.76M | -53.13M | -54.66M | -53.54M | -65.61M | -63.07M | -62.52M | -56.97M | -50.69M | -51.73M | -48.3M | -48.71M | -42.85M |
Interest Income | 693.42K | 693.42K | 833.22K | 899.09K | 890.03K | 890.03K | 701.35K | 395.54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 21.12M | -46.81M | -75.36M | -94.05M | -159.13M | -51.49M | -58.98M | -60.33M | -57.2M | -70.25M | -66.05M | -65.11M | -59.77M | -53.17M | -53.16M | -49.68M | -43.77M | -36.36M |
Net Income | 21.12M | -46.81M | -75.37M | -94.05M | -159.13M | -51.5M | -58.98M | -60.34M | -57.2M | -70.25M | -66.05M | -65.11M | -59.77M | -53.17M | -53.16M | -49.68M | -40.5M | -33.09M |
Selling & General & Admin | 38.65M | 36.09M | 29.94M | 27.1M | 25.78M | 26.64M | 26.67M | 24.16M | 22.89M | 23.29M | 20.74M | 19.24M | 16.4M | 13.8M | 12.77M | 11.66M | 12.02M | 9.88M |
Research & Development | 37.79M | 46.89M | 41.76M | 34.18M | 34.08M | 21.12M | 26.45M | 30.5M | 30.65M | 42.32M | 42.33M | 43.28M | 40.57M | 36.88M | 38.96M | 36.65M | 36.59M | 32.44M |
Other Expenses | -28.51K | -29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 76.41M | 82.96M | 71.7M | 61.28M | 59.86M | 47.76M | 53.13M | 54.66M | 53.54M | 65.61M | 63.07M | 62.52M | 56.97M | 50.69M | 51.73M | 48.3M | 40.22M | 33.94M |
Interest Expense | 18.5K | 3.08M | 3.08M | 3.08M | 3.08M | 303.00 | 2.45M | 2.81M | 3.17M | 3.58M | 1.49M | 1.4M | 1.3M | 1.13M | 936.13K | 685.98K | 872.73K | 1.32M |
Selling & Marketing Expenses | 298.00 | 298.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 76.44M | 82.99M | 71.7M | 61.28M | 59.86M | 47.76M | 53.13M | 54.66M | 53.54M | 65.61M | 63.07M | 62.52M | 56.97M | 50.69M | 51.73M | 48.3M | 48.6M | 42.32M |
Income Tax Expense | 2.8K | 2.8K | 2.8K | 2.8K | 2.8K | 2.8K | 2.8K | 3.6K | 3.6K | 2.8K | 2.8K | 2K | 2K | 2K | 2K | 1.2K | -3.27M | -3.27M |
Shares Outstanding (Basic) | 30.87M | 24.23M | 18.55M | 23.28M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M | 7.54M | 6.09M |
Shares Outstanding (Diluted) | 30.87M | 24.23M | 18.55M | 25.48M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M | 7.54M | 6.09M |
EPS (Basic) | 1.44 | -5.07 | -6.65 | -7.96 | -11.48 | -3.99 | -4.73 | -5.08 | -5.07 | -6.35 | -6.35 | -6.59 | -6.39 | -6.33 | -7.1 | -7.7 | -6.96 | -12.42 |
EPS (Diluted) | -1.35 | -7.86 | -9.44 | -10.75 | -11.48 | -3.99 | -4.73 | -5.08 | -5.07 | -6.35 | -6.35 | -6.59 | -6.39 | -6.39 | -7.16 | -7.76 | -7.02 | -12.42 |
EBITDA | 16.22M | 9.67M | 20.95M | -1.51M | -66.61M | -54.53M | -59.91M | -57.1M | -53.41M | -65.44M | -63.82M | -62.98M | -57.89M | -51.81M | -51.96M | -48.7M | -42.53M | -34.59M |
EBIT | 16.1M | 9.55M | 20.84M | -1.61M | -66.69M | -54.59M | -59.95M | -57.19M | -53.53M | -65.61M | -64.03M | -63.18M | -58.1M | -52.04M | -52.23M | -48.99M | -42.9M | -35.05M |
Depreciation & Amortization | 115.37K | 114.47K | 113.86K | 96.28K | 78.8K | 61.6K | 44.19K | 84.44K | 124.52K | 164.6K | 204.69K | 203.9K | 200.81K | 231.89K | 262.14K | 291.62K | 365.73K | 459.84K |